H. K. Polat Et Al. , "Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation," Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6, pp.412-423, 2022
Polat, H. K. Et Al. 2022. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation. Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6 , 412-423.
Polat, H. K., KURT, N., AYTEKİN, E., Akdaǧ Çayll, Y., Bozdaǧ Pehlivan, S., & Çallş, S., (2022). Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation. Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6, 412-423.
Polat, Heybet Et Al. "Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation," Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6, 412-423, 2022
Polat, Heybet K. Et Al. "Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation." Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6, pp.412-423, 2022
Polat, H. K. Et Al. (2022) . "Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation." Journal of Ocular Pharmacology and Therapeutics , vol.38, no.6, pp.412-423.
@article{article, author={Heybet Kerem Polat Et Al. }, title={Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation}, journal={Journal of Ocular Pharmacology and Therapeutics}, year=2022, pages={412-423} }